12FF
KRAS G12V in complex with GDP and a macrocyclic inhibitor (Compound 20).
This is a non-PDB format compatible entry.
Summary for 12FF
| Entry DOI | 10.2210/pdb12ff/pdb |
| Descriptor | Isoform 2B of GTPase KRas, MAGNESIUM ION, (5S,9R,21bP)-25-fluoro-3-{[(2R,4R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}-9-methyl-7,8,9,10,14,15,16,19-octahydro-13H-5,9-methano-22,1-(metheno)pyrimido[4',5':9,10][1,3,8]oxadiazacyclononadecino[14,15-e]indazol-11(6H)-one, ... (6 entities in total) |
| Functional Keywords | kras, gtp, gdp, g12v, hydrolase |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 4 |
| Total formula weight | 82420.91 |
| Authors | |
| Primary citation | Phillips, D.P.,Alper, P.B.,Borkin, D.,Han, D.,Kochanek, S.E.,Gurjar, J.,Mathison, C.J.N.,Nelson, J.M.,Pei, W.,Nguyen, B.N.,Hoffman, T.,Okram, B.,Nguyen, T.N.,Jiang, S.,Masick, B.T.,Wang, Z.,Cho, C.Y.,Yin, H.,Chen, Y.,Juarez, J.,Jia, Y.,Zhou, V.,Liu, G.,Wright, C.,Nguyen, T.,Knee, D.A.,Liu, Q.,Liu, J.,Li, J.,Virata, C.,de Oliveira, C.,DiDonato, M.,Bursulaya, B.,Vidal-Biggart, A.,Jones, D.H.,Witmer, D.,Chu, C.,Jin, H.,Herath, A.,Richmond, W.,Groessl, T.,Shapiro, M.,Effenberger, K.,Arroyo, K.,Bretz, A.,Honda, A.,Gordon, W.P.,Molteni, V.,Haling, J.R. Lead Optimization of Multimutant KRAS Switch-II Pocket Macrocyclic Inhibitors via Isosteric Replacement to Improve ADME and Oral Exposure J.Med.Chem., 2026 Cited by DOI: 10.1021/acs.jmedchem.6c01454PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.1 Å) |
Structure validation
Download full validation report






